Equites Radar

WH · Wyndham Hotels & Resorts, Inc.

LodgingUnited StatesAnalyst view: Buy

$72.42

-3.53% last session

End-of-day data · close of 2026-10-23

Mildly bearish2 bullish · 3 bearish technical signals
Consensus: Buy (1.56 from 18 analysts)
To mean target: +32.8%

Market cap

$5B

Enterprise value

$8B

Trailing P/E

26.5

Forward P/E

13.6

Dividend yield

2.0%

Beta

—

Avg volume

1M

Employees

2K

Daily Change %

-3.53%

5 Days Change

-0.70%

10 Days Change

2.25%

30 Days Change

8.31%

60 Days Change

1.60%

Month to Day Change

5.01%

Year to Day Change

1.07%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.56
Covering analysts18
Mean price target$96.17
Low price target$80.00
Upside to mean target+32.8%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)46.9
50-day MA$72.19
200-day MA$77.27
Price vs 50-day MA+0.3%
Price vs 200-day MA-6.3%
MACD histogram0.11
Volume vs 3-month avg1.8×
52w low $67.1552w high $88.87

Analyst sentiment over time — WH

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-10-23

Latest call per bank · past 12 months

Barclays

Overweight

$101

+39.5% vs price
▼ cut from $102Maintains · 2026-10-23

Morgan Stanley

Overweight

$97.00

+33.9% vs price
▲ raised from $92.00Maintains · 2026-10-22

JP Morgan

Overweight

$97.00

+33.9% vs price
▼ cut from $100Maintains · 2026-07-21

Wells Fargo

Equal-Weight

$98.00

+35.3% vs price
▲ raised from $96.00Maintains · 2026-07-16

Goldman Sachs

Neutral

$76.00

+4.9% vs price
▼ cut from $88.00Downgrade · 2025-12-15

Recent rating actions

DateFirmActionRatingPrice target
2026-10-23BarclaysMaintainsOverweight$102 → $101
2026-10-23BairdMaintainsOutperform$96.00 → $95.00
2026-10-22Morgan StanleyMaintainsOverweight$92.00 → $97.00
2026-10-22StifelMaintainsBuy$98.00 → $99.00
2026-10-14Freedom BrokerInitiatesBuy$0.00 → $88.00
2026-10-12Morgan StanleyMaintainsOverweight$91.00 → $92.00
2026-09-10Truist SecuritiesMaintainsBuy$107 → $104
2026-08-18Morgan StanleyMaintainsOverweight$93.00 → $91.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-10-23

  • neutral: RSI (14): RSI is 47 — neutral momentum, neither overbought nor oversold.
  • bullish: Price vs 50-day MA: Trading 0.3% above the 50-day MA ($72.19).
  • bearish: Price vs 200-day MA: Trading 6.3% below the 200-day MA ($77.27).
  • bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • bullish: MACD (12,26,9): MACD histogram is positive (+0.11) — short-term momentum is improving.
  • bearish: 52-week range: Price is within 10% of the 52-week low ($67.15).

WH Price Chart

Loading chart for WH…

Fundamentals

Revenue (TTM)$1.0B
EBITDA$1.0B
Free cash flow$0M
Operating cash flow$0M
Book value / share$6.41
Net Debt / EBITDA4.8
WACC2.0%
Revenue growth7.00%
Earnings growth-2.00%

About Wyndham Hotels & Resorts, Inc.

Wyndham Hotels & Resorts, Inc. is the world's largest hotel franchising company by the number of franchised properties, with approximately 8,300 hotels across approximately 100 countries on six continents. Through its network of over 855,000 rooms appealing to the everyday traveler, Wyndham commands a leading presence in the economy and midscale segments of the lodging industry. The Company operates a portfolio of 25 hotel brands, including Super 8, Days Inn, Ramada, Microtel, La Quinta, Baymont, Wingate, AmericInn, ECHO Suites, Registry Collection Hotels, Trademark Collection and Wyndham. Wyndham Hotels & Resorts, Inc. was incorporated in 2017 and is headquartered in Parsippany, New Jersey.

More in Lodging

Screen WH against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.